BIOCEPT, INC. Net Change in Cash
BIOCEPT, INC. reported Net Change in Cash of -$6.26 million for the 6-month period ending 2023-06-30, per its 10-Q filed 2023-08-14.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect · last filed 2023-08-14
- BIOCEPT, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2023-03-31 was -$6.12M.
- BIOCEPT, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2022-03-31 was -$1.30M.
- BIOCEPT, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2021-03-31 was -$170.00K, a 101.39% decline year-over-year.
- BIOCEPT, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2020-03-31 was $12.19M, a 7.52% increase year-over-year.
- BIOCEPT, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2022 was -$15.97M, a 210.15% decline from fiscal 2021.
- BIOCEPT, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2021 was $14.50M, a 186.09% increase from fiscal 2020.
- BIOCEPT, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2020 was $5.07M, a 13.80% decline from fiscal 2019.
- BIOCEPT, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2019 was $5.88M, a 360.39% increase from fiscal 2018.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3 month as first filed | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6 month as first filed | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 9 month as first filed | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 12 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2023-06-30 | -$6.26M 10-Q · filed 2023-08-14 | |||||||
| 2023-03-31 | -$6.12M 10-Q · filed 2023-05-10 | |||||||
| 2022-12-31 | -$15.97M 10-K · filed 2023-04-17 | |||||||
| 2022-09-30 | -$10.84M 10-Q/A · filed 2023-04-17 | |||||||
| 2022-06-30 | -$5.94M 10-Q · filed 2023-08-14 | |||||||
| 2022-03-31 | -$1.30M 10-Q · filed 2023-05-10 | |||||||
| 2021-12-31 | $14.50M 10-K · filed 2023-04-17 | |||||||
| 2021-09-30 | $13.33M 10-Q/A · filed 2023-04-17 | $13.33M 10-Q · filed 2021-11-15 | ||||||
| 2021-06-30 | $5.08M 10-Q · filed 2022-11-10 | $5.08M 10-Q · filed 2021-08-16 | ||||||
| 2021-03-31 | -$170.00K 10-Q · filed 2022-05-23 | -$170.40K 10-Q · filed 2021-05-12 | ||||||
| 2020-12-31 | $5.07M 10-K · filed 2022-04-05 | $5.07M 10-K · filed 2021-03-31 | ||||||
| 2020-09-30 | $7.56M 10-Q/A · filed 2022-02-15 | |||||||
| 2020-06-30 | $14.75M 10-Q · filed 2021-08-16 | |||||||
| 2020-03-31 | $12.19M 10-Q · filed 2021-05-12 | |||||||
| 2019-12-31 | $5.88M 10-K · filed 2021-03-31 | |||||||
| 2019-09-30 | $3.12M 10-Q · filed 2020-11-16 | |||||||
| 2019-06-30 | $9.17M 10-Q · filed 2020-08-13 | |||||||
| 2019-03-31 | $11.34M 10-Q · filed 2020-05-14 | |||||||
| 2018-12-31 | $1.28M 10-K · filed 2020-03-27 | |||||||
| 2018-09-30 | $6.81M 10-Q · filed 2019-11-13 |